If Bayer does purchase CropScience, it will further drivehomeapoint that has increasingly become apparent to anyone watching the pharmaceutical industry: The drug business does not leave energy for diversification.
And even if they did bring them home, such a dramatic influx of metals onto the marketplace could drive down commodity prices to the point where mining doesn't make economic sense.